$AIHC

Health In Tech, Inc. reported strong Q4 2025 earnings, beating analysts' expectations with revenues of $200 million, a 15% increase from Q4 2024. The company's expansion into artificial intelligence-driven healthcare solutions is a key driver of growth as they have secured several high-profile partnerships. Health In Tech also announced a 10% dividend increase, signaling financial stability and commitment to shareholder returns. Despite some challenges in regulatory compliance, the overall sentiment is positive due to robust financial performance and future growth potential. Analysts have upgraded their price targets, reflecting renewed investor confidence.